Jacobs Levy Equity Management’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $906K | Sell |
192,663
-49,153
| -20% | -$231K | ﹤0.01% | 773 |
|
|
2025
Q1 | $883K | Buy |
241,816
+18,036
| +8% | +$65.8K | ﹤0.01% | 830 |
|
|
2024
Q4 | $1.06M | Buy |
223,780
+94,449
| +73% | +$446K | ﹤0.01% | 707 |
|
|
2024
Q3 | $1.2M | Sell |
129,331
-54,973
| -30% | -$512K | ﹤0.01% | 692 |
|
|
2024
Q2 | $1.06M | Sell |
184,304
-31,966
| -15% | -$184K | ﹤0.01% | 728 |
|
|
2024
Q1 | $1.45M | Buy |
216,270
+108,700
| +101% | +$729K | 0.01% | 647 |
|
|
2023
Q4 | $694K | Buy |
107,570
+58,704
| +120% | +$379K | ﹤0.01% | 783 |
|
|
2023
Q3 | $244K | Sell |
48,866
-6,988
| -13% | -$34.9K | ﹤0.01% | 899 |
|
|
2023
Q2 | $393K | Sell |
55,854
-74,993
| -57% | -$528K | ﹤0.01% | 851 |
|
|
2023
Q1 | $811K | Buy |
+130,847
| New | +$811K | 0.01% | 738 |
|